FDA Approves CLONAZEPAM — Advagen Pharma Ltd

# FDA Approves Generic Clonazepam ANDA for Advagen Pharma Ltd Advagen Pharma Ltd has received FDA approval for its abbreviated new drug application (ANDA216988) for generic clonazepam oral formulation, expanding the competitive landscape in the benzodiazepine market and potentially increasing pricing pressure on branded alternatives. The approval is expected to enhance patient access to this widely-prescribed anxiolytic and anticonvulsant medication while offering cost-saving opportunities for healthcare systems and insurers.